The PainPREDICT questionnaire – an instrument for stratifying pain patients: validation and comparison of the PainPREDICT questionnaire with quantitative sensory testing and bedside sensory testing
- Conditions
- R52.2R52.1Chronic intractable painOther chronic pain
- Registration Number
- DRKS00031413
- Lead Sponsor
- KSH Universitätsklinikum Schleswig-Holstein. Neurologische Schmerzforschung und -therapie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Patients suffer from at least moderate chronic pain (NRS>=3)
- Minimum age 18 years
- Ability to give consent
-Major depression
- Chronic alcohol abuse (regular consumption of alcohol that exceeds 10 g per day for women and 20 g per day for men)
-Chronic substance abuse. Includes any illicit drugs and prescription medications such as opioids or benzodiazepines not prescribed to the patient or used in excessive doses
-The use of medicinal cannabis or medicinal CBD or THC preparations, as well as the consumption of CBD preparations that fall under the Dietary Supplement Ordinance under German law is permitted.
-Patients who use cannabis without a doctor's prescription or who do not obtain it from a pharmacy or licensed dispensary will be excluded from the study.
-Patients who are currently participating in drug studies
-Any reason that prevents an adequate understanding of the investigations carried out
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Validation of the painPREDICT in direct comparison with (a) the QST and (b) the bedside sensory test
- Secondary Outcome Measures
Name Time Method -Enables the combination of painPREDICT and bedside sensory testing to better classify patients into sensory profiles.<br>-Finally, the painPREDICT should be assessed for sensitivity to changes.